Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by elgin1on Feb 12, 2022 2:02am
234 Views
Post# 34422770

RE:RE:SVA, SPEC BUY, PT $3.25 Potential 100% increase.

RE:RE:SVA, SPEC BUY, PT $3.25 Potential 100% increase.
elgin1 wrote:

 

rixpix wrote: Echelon commenced coverage with a spec buy and a $3.25 P.T. I can live with that. :))

 

Ripper,

That was already posted a few days ago . Wally originslly posted it before anyone and it was posted on the blog by Mercury I believe so don't get too excited .

The market is going to crash here in the next few weeks , taking  everything down with it. Might be like the 87 crash.

MS
 



Rixpix,

It was refreshing to see a nice analyst report . Thorough analysis , objective . Obviously management had been consulted . I like the market potential of Billions , not sure if Sva will qualify for Nasdaq this year or when conformal coating clinical trial will begin , but I'll take that price target .

Finally having a few analysts on board will give credibility and legitimacy to the company.  And it couldn't have been better than from Doug Loe's former firm Echelon.

Btw Don't let MS bully you.


 

<< Previous
Bullboard Posts
Next >>